戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 lly separated from the seeds and plants by a dialysis membrane.
2 sues, and was finally eliminated through the dialysis membrane.
3 d organic carbon) of SRFA passed through the dialysis membrane.
4 ble species across the lipid bilayer and the dialysis membrane.
5 branes increases the biocompatibility of the dialysis membranes.
6 s a relevant feature for characterization of dialysis membranes.
7  USP 2 apparatus in conjunction with reverse-dialysis membranes.
8 d and measured drug concentration inside the dialysis membranes.
9 liver support or treatment with conventional dialysis membranes.
10 mine the diffusion barrier properties of the dialysis membranes.
11 0) nanoparticles that readily diffuse across dialysis membranes.
12       Bisphenol A (BPA), a component of some dialysis membranes, accumulates in CKD.
13 e analyte diffusive driving force across the dialysis membrane and a subsequent increase in the relat
14 riving force for analyte to pass through the dialysis membrane and thus increases the RR.
15  relative recovery of the analyte across the dialysis membrane and yielded for the first time quantit
16  due to the development of new materials for dialysis membranes and commercial availability of smalle
17  taxane that otherwise bound irreversibly to dialysis membranes and which exhibited distinctive lipop
18 -limiting factors, such as diffusion through dialysis membrane, and has potential to be extended furt
19                The effects of dialysis dose, dialysis membrane, and other clinical parameters on infe
20 ed through a 100-500 molecular weight cutoff dialysis membrane, and the dialysate and retentate were
21 f desalting methods, including spin columns, dialysis membranes, and filters.
22                                              Dialysis membranes are typically used for buffer exchang
23 sed attention on the biocompatibility of the dialysis membrane as a possible factor influencing patie
24 sing single Sephadex beads as osmometers and dialysis membranes as protein filters.
25 ive ELISA performed in tubes or wells with a dialysis membrane attached to their bottoms.
26    In this article, we review the concept of dialysis membrane biocompatibility and highlight the dif
27 bound solutes than do conventional high-flux dialysis membranes but at the cost of some albumin loss
28 s are catalytically reduced to NO within the dialysis membrane by the immobilized organoselenium spec
29 this regard, several studies have utilized a dialysis membrane chamber (DMC) cultivation system to ge
30  that although widely dissimilar, the UT and dialysis membrane chamber growth conditions promote more
31  not able to grow in dilute BSK-II medium or dialysis membrane chambers (DMCs) implanted in rats.
32 nd host adaptation of lp25-B. burgdorferi in dialysis membrane chambers (DMCs) implanted in rats.
33 hanced upon growth of the spirochetes within dialysis membrane chambers (DMCs) implanted intraperiton
34 ian host-adapted organisms cultivated within dialysis membrane chambers (DMCs) implanted within the p
35 rotein was expressed by spirochetes grown in dialysis membrane chambers (DMCs).
36  were able to survive within intraperitoneal dialysis membrane chambers at a level equivalent to that
37  strain 297 cultivated either in vitro or in dialysis membrane chambers implanted in rat peritoneal c
38 , or during mammalian host adaptation (Bb in dialysis membrane chambers implanted in rats).
39 with "host-adapted" spirochetes grown within dialysis membrane chambers implanted into the peritoneal
40 ort, we cultivated B. burgdorferi 297 within dialysis membrane chambers implanted into the peritoneal
41 ities of B. burgdorferi grown in vitro or in dialysis membrane chambers implanted intraperitoneally i
42  relatively immune-privileged environment of dialysis membrane chambers implanted within the peritone
43 were able to survive as well as wild type in dialysis membrane chambers in the rat peritoneum.
44 g the complete set of plasmids were grown in dialysis membrane chambers that were implanted into rat
45 RpoS regulon was uniquely upregulated within dialysis membrane chambers, further underscoring the imp
46 ations after cultivation in vitro and within dialysis membrane chambers, mimicking a mammalian host-a
47 mmalian host-adapted organisms cultivated in dialysis membrane chambers.
48 d following mammalian host-adaptation within dialysis membrane chambers.
49     When nanoblends and MC were separated by dialysis membrane colorimetric response (CR) was similar
50                             State-of-the-art dialysis membranes comprise a relatively thick polymer l
51 crofluidics system that uses cellulose ester dialysis membranes coupled with disposable carbon and co
52 for the released drug to diffuse through the dialysis membrane delays its appearance in the sampling
53 de a sealed, small segment of a hollow fiber dialysis membrane (diameter 0.5 mm, length 0.5 cm, molec
54                          The new device uses dialysis membranes (DMs) paired with ion exchange membra
55                                              Dialysis membrane experiments showed that direct contact
56 on approach for Si(OH)(4)(0) that utilizes a dialysis membrane filled with ferrihydrite ("Iron Bag").
57 e presence of Alnus roots but separated by a dialysis membrane for 64 h.
58 e necessary electrical connection across the dialysis membrane for defining the electric fields neede
59               Commercial ultrafiltration and dialysis membranes have broad pore size distributions an
60                         These methods employ dialysis membranes in 96-well format or spin filters.
61 bile salt and complete porcine bile across a dialysis membrane, in the presence and absence of two ce
62 e beta2m with transition metal cation at the dialysis membrane interface is causal to dialysis relate
63        A key component of its apparatus is a dialysis membrane interface that eliminates electrolysis
64 passively diffuse from the brain through the dialysis membrane into an infusion solution which is the
65             By taking the barrier effects of dialysis membranes into consideration, our model indepen
66 that, for a 15 kDa polyelectrolyte, a 50 kDa dialysis membrane is not sufficient to remove all PAH po
67  when a 1000 MWCO (molecular weight cut off) dialysis membrane is placed in the front of the diffusiv
68                                            A dialysis membrane is sandwiched between the disks to for
69 s sensor with a thin organoselenium modified dialysis membrane mounted at the distal sensing tip.
70 e conditions of the event, cellulose acetate dialysis membranes of various ages were retrieved from o
71 study investigates the potential role of the dialysis membrane on patient outcome in a prospective mu
72 ral clinical studies analyzing the impact of dialysis membranes on the course and outcome of acute re
73 trode consisted of nitrate reductase held by dialysis membrane onto a Nafion-coated glassy carbon ele
74 ally reduced upon elimination of copper from dialysis membranes, our results provide a molecular unde
75                         In this study, a rat dialysis membrane peritoneal model was used to evaluate
76 s concluded that the biocompatibility of the dialysis membrane plays a role in the outcome of patient
77                                              Dialysis membranes ranging from 3 kD to 100 kD were used
78 rganisms and the electrodes was prevented by dialysis membrane, suggesting that soluble electron carr
79 se and 6-phosphogluconate dehydrogenase by a dialysis membrane, there was no apparent channeling.
80 iffusion performance of anthocyanins along a dialysis membrane was determined in the presence and abs
81 n performance of nine anthocyanins through a dialysis membrane was evaluated in the presence and abse
82    Using molecular weight cutoff filters and dialysis membranes, we found that the molecular weight o
83 m the antibiotic-resistant mutant by using a dialysis membrane were carried out.
84 monium chloride (PDA) aqueous solution and a dialysis membrane were used as a binding phase and a dif
85                                Treating AN69 dialysis membrane, which bears negative charge due to in
86 s of complement and neutrophil activation by dialysis membranes, which may prolong the recovery from
87 n escape from 25,000 molecular weight cutoff dialysis membranes with velocity constants of 5.1 x 10(-